刚果民主共和国2017至2023年疫苗接种覆盖率与公平性趋势
该分析基于2017—2018年MICS-Palu调查及2020—2023年四次年度接种覆盖率调查,描述刚果民主共和国儿童五价疫苗第三剂(Penta3)和含麻疹成分疫苗首剂(MCV1)覆盖率及按母亲教育和家庭财富衡量的不平等趋势。2017至2023年全国Penta3覆盖率上升9.9个百分点(47.7%至57.6%),MCV1下降6.7个百分点(58.9%至52.2%);2023年最富裕家庭儿童获得Penta3的可能性是最贫困家庭儿童的2.23倍(95%CI 2.16-2.31)。
要点
- 2017至2023年全国Penta3覆盖率上升9.9个百分点,MCV1覆盖率下降6.7个百分点。
- 2023年最富裕家庭儿童获得Penta3的可能性是最贫困家庭儿童的2.23倍(95%CI 2.16-2.31)。
- 2017至2023年财富相关不平等似有下降但差异无统计学意义,教育相关不平等改善较小。
核心结论
- 刚果民主共和国在实现常规免疫覆盖率和公平性目标方面仍需努力。
- 应定期开展常规免疫覆盖率不平等的常规监测以追踪进展。
- 常规免疫强化举措中可能需要更明确的公平性关注,以加速缩小现有不平等。
研究设计与样本
- 基于人群的调查分析,包括2017—2018年MICS-Palu调查和2020至2023年四次年度疫苗接种覆盖率调查。
- 在全国层面及两组省份(2018年最初纳入Mashako计划的省份和最初纳入备忘录共识(MOU)方式的省份)分析Penta3和MCV1覆盖率。
- 采用随机效应DerSimonian and Laird估计量合并各省份组的不平等估计。
主要发现
- 2017至2023年全国Penta3覆盖率从47.7%上升至57.6%,提高9.9个百分点;MCV1覆盖率从58.9%下降至52.2%,降低6.7个百分点。
- 2023年全国最富裕家庭儿童获得Penta3的可能性是最贫困家庭儿童的2.23倍(95%CI 2.16-2.31)。
- 2017至2023年财富相关的绝对和相对不平等似有下降,但差异无统计学意义;教育相关不平等的改善小于财富相关不平等。
- 不平等降幅在最初纳入Mashako计划和MOU方式的省份通常大于未最初纳入任一举措的省份,但差异常无统计学意义。
- 2017至2020—2021年的初始覆盖率和公平性改善在2022和2023年于全国和次国家层面大体停滞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Several routine immunization (RI) strengthening efforts have been implemented in the Democratic Republic of the Congo (DRC) in the last decade. However, there has been no assessment of national or provincial-level trends in inequalities in RI coverage since the implementation of these programs. In this analysis, we aimed to describe trends in childhood vaccination coverage and inequalities from 2017 to 2023 at the national and provincial levels and to compare these trends among groups of provinces where two initiatives have been in place: the Mashako plan and a provincial level public-private partnership using a memorandum of understanding (MOU) approach. MATERIALS AND METHODS: We used population-based surveys including the Multiple Indicator Cluster Survey (MICS) - Palu 2017-2018 survey and four annual vaccination coverage surveys conducted from 2020 through 2023. We described vaccination coverage (three doses of pentavalent vaccine (Penta3) and at least one dose of a measles containing vaccine (MCV1)) and assessed relative and absolute inequalities in vaccination coverage by maternal education and household wealth at each time point. Analyses were conducted at the national level and within two groups of provinces: those initially included in the Mashako plan in 2018 and those initially included in the MOU approach. Inequality estimates were pooled across province groups using a random effects DerSimonian and Laird estimator for meta-analysis. RESULTS: From 2017 to 2023, national Penta3 coverage increased by 9.9 percentage points (47.7 % to 57.6 %) while MCV1 declined by 6.7 percentage points (58.9 % to 52.2 %). As of 2023, substantial wealth and education-related inequalities in childhood vaccination coverage remained: at the national level, children from wealthier households were 2.23 times more likely to receive Penta3 compared to children from poorest households (95 % Confidence Interval (CI) 2.16-2.31). Between 2017 and 2023, absolute and relative wealth-related inequalities appear to have declined, but differences were not statistically significant. Education-related inequalities have improved less than wealth-related inequalities. Though differences were often not statistically significant, reductions in inequalities were generally larger in provinces initially included in the Mashako plan and the MOU approach than in provinces not initially included in either initiative. Initial improvements in coverage and inequality between 2017 and 2020-2021 have largely stagnated at the national and sub-national levels in 2022 and 2023. DISCUSSION: Efforts remain needed to reach RI coverage and equity targets in the DRC. Routine monitoring of inequalities in RI coverage should be performed regularly to track progress. A more explicit equity focus in RI strengthening initiatives in the DRC may be necessary to accelerate progress in reducing existing inequalities.
引用
- Lankiewicz E, Mpemba JKN, Dikassa PSL, et al. Trends in vaccination coverage and equity in the Democratic Republic of the Congo from 2017 to 2023. Vaccine. 2025. PMID: 40818261. doi:10.1016/j.vaccine.2025.127609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。